Amy Falk Russell

Immunogenicity and safety of an investigational tetravalent recombinant subunit vaccine for dengue: results of a Phase I randomized clinical trial in flavivirus-naïve adults

Susan B. Manoff, Michele Sausser, Amy Falk Russell et al. · Human Vaccines & Immunotherapeutics · 2018 · 66 citations · Full text

Safety, tolerability, and immunogenicity of zoster vaccine in subjects on chronic/maintenance corticosteroids

Amy Falk Russell, Janie Parrino, Chester Fisher et al. · Vaccine · 2015 · 36 citations

Vaccination, Vaccine Safety, Chronic/maintenance Corticosteroids +10

A phase I randomized, double-blind, placebo-controlled study to evaluate the safety, tolerability, and immunogenicity of a live-attenuated quadrivalent dengue vaccine in flavivirus-naïve and flavivirus-experienced healthy adults

Kevin L. Russell, Richard Rupp, Javier O Morales-Ramirez et al. · Human Vaccines & Immunotherapeutics · 2022 · 30 citations · Full text

Safety and Immunogenicity of Zoster Vaccine Live in Human Immunodeficiency Virus–Infected Adults With CD4+ Cell Counts >200 Cells/mL Virologically Suppressed on Antiretroviral Therapy

Constance A. Benson, Janet W. Andersen, Bernard Macatangay et al. · Clinical Infectious Diseases · 2018 · 27 citations · Full text

Immunogenicity and Safety of a Tetravalent Recombinant Subunit Dengue Vaccine in Adults Previously Vaccinated with a Live Attenuated Tetravalent Dengue Vaccine: Results of a Phase-I Randomized Clinical Trial

Anna P. Durbin, Kristen K. Pierce, Beth D. Kirkpatrick et al. · American Journal of Tropical Medicine and Hygiene · 2020 · 27 citations · Full text